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Angiotensin II (ANG II), a bioactive peptide well
known to play an important role in blood-pressure
and body-fluid regulation, seems to participate in
inflammatory responses, too.  For example, ANG II
induces an inflammatory response—involving in-
creases in the expressions of such proinflammatory
enzymes as phospholipase (Schlondorff et al., 1987)
and NADPH oxidase (Griendling et al., 1994)—and
ANG-II-type-1 (AT1) receptors are involved in cer-
tain types of cardiovascular inflammation (Usui et
al., 2000).  Furthermore, angiotensin-converting-
enzyme (ACE) inhibitors have an anti-inflamma-
tory effect (Delfraissy et al., 1984; Martin et al.,
1984; Rezkalla et al., 1990).  Recently, we reported
results suggesting that ANG II is involved in the
development of the fever (another example of an in-
flammatory response) induced by lipopolysaccha-
ride (LPS) in rats (Watanabe et al., 2000).  In fact,
the LPS-induced fever seen by us in rats was signif-
icantly attenuated by an ACE inhibitor.  Since, as
the first step in fever induction, the pyrogenic/pro-
inflammatory cytokine interleukin-1 (IL-1) is re-
leased from macrophages following their stimula-
tion with LPS (Dinarello, 1984; Kluger, 1991), we
next examined the effect of the same ACE inhibitor
on the fever induced by IL-1.  However, this fever
underwent no alterations with the ACE inhibitor
(Watanabe et al., 2000), so we concluded that ANG
II contributes to the LPS-induced production of IL-
1 in rats.
It has repeatedly been suggested that the LPS-
induced production of IL-1 in the tissues results in
the local induction of IL-6 and that this then enters
the general circulation to cause fever (Kluger, 1991;
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Angiotensin II (ANG II) has been shown to have proinflammatory properties.  To investigate
whether ANG II is involved in the lipopolysaccharide (LPS)-induced production of a
pyrogenic/proinflammatory cytokine, interleukin-6 (IL-6), we examined the effects of an
angiotensin-converting-enzyme (ACE) inhibitor, lisinopril, on LPS-induced fever and on
the expression of IL-6 mRNA in the spleen of dehydrated rats (in which the secretion of
ANG II increases).  The results showed that the ACE inhibitor significantly inhibited
LPS-induced fever as well as the splenic expression of IL-6 mRNA in dehydrated rats.  It
is suggested that endogenous ANG II may be involved in the production of IL-6 that occurs
in response to LPS, and thereby contribute to the LPS-induced febrile response in de-
hydrated rats.
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Luheshi et al., 1997; Luheshi, 1998).  For that
reason, IL-6 is now thought to be a candidate for a
circulating pyrogenic cytokine (Kluger, 1991).
Moreover, there is an undetectable amount of IL-1β
in the blood of animals treated with LPS (Kluger,
1991).  Taking the above evidence together, it seems
likely (i) that ANG II participates in the production
of tissue IL-1 in response to LPS and (ii) that the
local induction of IL-6 by this IL-1 might be, at
least in part, involved in the development of the
LPS-induced fever after the entering general circu-
lation and acting on the brain as a circulating pyro-
genic cytokine.
The present study was carried out to investi-
gate whether the LPS-induced production of IL-6
does indeed involve an action by ANG II.  To this
end, the effects of an ACE inhibitor on LPS-
induced fever and on the expression of IL-6 mRNA
in the spleen, a representative organ of the reticulo-
endothelial system, were examined in dehydrated
rats.  Dehydrated rats (in which the secretion of
ANG II increases) were chosen, because, in our pre-
vious study (Watanabe et al., 2000), although the
LPS-induced fever was significantly attenuated by
an ACE inhibitor in both dehydrated and euhydrat-
ed rats, the effect was greater in the former.   The
present results showed that ACE inhibition signifi-
cantly inhibited both LPS-induced fever and the
splenic expression of IL-6 mRNA in dehydrated
rats, suggesting that ANG II is involved in the LPS-
induced production of IL-6 in such rats.
Materials and Methods
Animals
The animals used in this study were male Wistar
rats, weighing 270–350 g.  They were housed in
individual plastic cages (40 × 25 × 25 cm; length ×
width × depth) with wood-chip bedding in a room
maintained at 26 ± 1˚C, a temperature within the
thermoneutral zone for rats.  They experienced a
photoperiod of 12 h light:12 h dark, lights coming
on at 0700.   All animals had ad libitum access to
drink and standard laboratory rat chow.  The proto-
cols were reviewed by the Committee on the Ethics
of Animal Experiments in Tottori University Facul-
ty of Medicine, and the experiments were carried
out in accordance with the Guidelines for Animal
Experiments at Tottori University Faculty of Medi-
cine and with the Federal Law (No. 221) and Notifi-
cation (No.6) of the Japanese Government.
This study comprised 2 types of experiment
(see below), both on freely moving rats.  All rats
were dehydrated by deprivation of drinking water
for 24 h before experimentation.  The rats lost about
6% of their total body weight as a result of this de-
privation.
In Experiment 1, we investigated the effect of
an intravenous (i.v.) injection of an ACE inhibitor,
lisinopril (20 mg/kg), on the LPS (2 µg/kg, i.v.)-
induced fever in dehydrated rats.  In Experiment 2,
a single i.v. injection of lisinopril was given, and its
effect on the LPS-induced changes in the produc-
tion of IL-6 in the spleen was examined, the splenic
IL-6 mRNA being measured for this purpose.
Surgery
In Experiment 1, body temperature was measured
using a biotelemetry system (Lange et al., 1991;
Data Science Inc., St Paul, MN).  Each rat was anes-
thetized with intraperitoneally (i.p.) injected sodium
pentobarbitone (50 mg/kg) and a battery-operated
transmitter  (model TA10TA-F40, Data Science)
implanted i.p.  The transmitter included a sensor
and a radiofrequency transmitter.  The output of the
transmitter was monitored by antennae mounted in
a receiver board (model CTR86, Data Science) plac-
ed under each animal’s cage.  The data were fed into
a peripheral processor (matrix model BCM100,
Data Science) connected to a Sanyo MBC-17J AX
computer (IBM compatible) (Tokyo, Japan).  The
implantation of the transmitter was performed at
least 1 week before the implantation of a venous
cannula for i.v. injections.
Rats with i.p. biotelemetry transmitters were
again anesthetized with sodium pentobarbitone (50
mg/kg, i.p.) and a polyvinyl tube was inserted into
the jugular vein so that its tip lay in the superior
caval vein near the right atrium (Harms and Ojeda,
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1974).  The free end of the catheter was passed
subcutaneously to the mid-scapular region, where it
was exteriorized dorsally behind the neck.  It was
kept patent by flushing it every day with heparini-
zed 0.9% saline (50 U/mL).  This implantation was
performed at least 3 days before the start of the
experiment.
In Experiment 2, the splenic expression of IL-
6 mRNA was measured in dehydrated rats without
transmitters.  For i.v. injections, rats were catheter-
ized as described above.
All rats were handled for 15 min each day for
at least 5 days to accustom them to the experi-
menters.
Drugs
The LPS used in this study, which was derived from
Salmonella typhosa endotoxin (Sigma, St. Louis,
MO), was dissolved in sterile saline.  Lisinopril
(Sigma) was also dissolved in sterile saline.  The
doses injected in each experimental group are given
below.
Experimental protocols
Experiment 1
Changes in body temperature were examined in
conscious rats following i.v. injection of LPS (2 µg/
kg).  Each rat received only 1 injection of LPS, be-
cause repeated injections result in febrile tolerance.
The injection of LPS was performed 30 min after an
i.v. injection of either lisinopril (20 mg/kg;
Lisinopril + LPS group) or saline (Saline + LPS
group).
On the day of the experiment, each rat was
gently picked up and its transmitter switched on
using a magnet.  The body temperature was then
allowed to stabilize for a period of 90 min before
any injections.  Each injectate was given i.v. to each
animal in a volume of 0.5 mL/kg over a  period of
30 s.  To minimize the influence of the rat’s own
circadian rhythm, LPS was always given between
1100 and 1200.
Experiment 2
Changes in the expression of IL-6 mRNA in the
spleen were examined in dehydrated rats following
an i.v. injection of LPS (2 µg/kg).  Either lisinopril
(20 mg/kg; Lisinopril + LPS group) or saline
(Saline + LPS group) was administered i.v. 30 min
before the injection of LPS.  The control rats receiv-
ed an i.v. injection of saline (vehicle for LPS) 30
min after i.v. saline (vehicle for lisinopril) (Saline +
saline group).  Animals were sacrificed by CO2
stunning followed by decapitation either 2 or 4 h
after their 2nd injection (LPS or saline) and the
spleen quickly removed, frozen and powdered in
liquid nitrogen.  This procedure was approved by
the Committee on the Ethics of Animal Experi-
ments in Tottori University Faculty of Medicine.
IL-6 mRNA:  The splenic expression of IL-6
mRNA was measured by Northern blot analysis.  In
brief, total RNA was extracted from each tissue by
the guanidinium-thiocyanate-phenol-chloroform
method (ISOGEN; Nippon Gene, Toyama, Japan).
The RNA (20 µg) was separated, according to size,
by electrophoresis on 1% agarose gels containing
6.6% formaldehyde, transferred to a nylon mem-
brane and subjected to hybridization.  The probes
were labelled with [α-32P] dCTP by the random-
priming method (BcaBEST labelling kit; Takara,
Ohtsu, Japan) and purified using ProbeQuant G-50
Micro Columns (Amersham Pharmacia Biotech,
Amersham, Bucks, United Kingdom).  After hy-
bridization, the membrane was washed under strin-
gent conditions, then subjected to autoradiography.
Images of the autoradiographs were taken into a
personal computer and analysed [Windows, Scion
Image, Plot Profile (Scion Corporation, Frederick,
MD)].  The density of the IL-6 mRNA fraction,
which was normalized with respect to the β-actin
density in each sample, is expressed in arbitrary
units.
Probes for Northern blot analysis were pre-
pared by RT-PCR. Briefly, cDNA was made from
rat spleen total RNA using an oligo(dT)17 primer by
means of the RT reaction.  Then, PCR fragments
derived from rat IL-6 and β-actin mRNA were
obtained; the fragments were of 719-bp and 762-bp,
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respectively.  The primers used for PCR were as
follows:  IL-6, sense, 5'-CTTCCAGCCAGTTGC
CTTCT-3' (Siegling et al., 1994), anti-sense, 5'-
GCCAGTTCTTCGTAGAGAAC-3' (Bourde et al.,
1996); β-actin, sense, 5'-CTATCGGCA-ATGAGC
GGTTC-3', anti-sense, 5'-CTTAGGAGTTGG
GGGTGGCT-3' (Siegling et al., 1994).  Each PCR
fragment was inserted into a T vector (pT7Blue;
Novagen, Darmstadt, Germany) and cloned in E. coli
(XL1-Blue; Stratagene, La Jolla, CA).  The T vectors,
which contained 1 of the above 2 PCR fragments,
were selected by sequencing.  Then, the T vectors
were digested with EcoRI and XbaI and the probes
isolated.
Statistical analysis
All results are expressed as the mean ± SEM.
The body temperature data (Experiment 1)
wereanalyzed for statistical significance using a
repeated-measures analysis of variance (ANOVA)
(Macintosh, StatView 4.0; Abacus Concepts, Inc.,
Berkeley, CA) to assess the overall effect.  Analysis
was performed on data collected from the time of
drug injection onwards, i.e. from time 0.
Fig. 1.  Effect of an angiotensin-converting enzyme (ACE) inhibitor on lipopolysaccharide (LPS)-induced fever in
dehydrated rats.  Mean values (± SEM) obtained for body temperature (˚C) in dehydrated rats after i.v. injection (at
time 0) of LPS (2 µg/kg).  An ACE inhibitor, lisinopril (20 mg/kg), or saline was administered i.v.  30 min before the
injection of LPS.  From repeated-measures ANOVA: for treatment effect, P < 0.05; for time effect, P < 0.0001; for
interaction, P > 0.0001.  [   ], number of subjects.
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A one-way ANOVA followed by Fisher’s
protected least significant difference test (post hoc
test) was used to analyze tissue IL-6 mRNA data
(Experiment 2).
Details of the results of the various forms of
analysis are given in the figure legends.  Differ-
ences were considered significant at P < 0.05.
Results
Effect of i.v. treatment with an ACE inhibi-
tor, lisinopril, on the LPS-induced fever un-
der dehydrated conditions (Experiment 1)
Figure 1 shows the effect of lisinopril (20 mg/kg,
i.v.) on the LPS (2 µg/kg, i.v.)-induced fever in
dehydrated rats.  A single i.v. injection of LPS in-
duced a biphasic increase in body temperature in
these rats with a latency of about 90 min.  This LPS-
induced fever was significantly attenuated by pre-
treatment with lisinopril (Lisinopril + LPS group
versus Saline + LPS group).
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Effect of i.v. treatment with an ACE inhibi-
tor, lisinopril, on the LPS-induced increase
in IL-6 mRNA expression in the spleen un-
der dehydrated conditions (Experiment 2)
Figure 2 depicts the effect of a single injection of
lisinopril (20 mg/kg, i.v.) on the LPS (2 µg/kg, i.v.)-
induced increase in IL-6 mRNA expression in the
spleen in dehydrated rats (Northern blot analysis).
Fig. 2.  Effect of an ACE inhibitor on LPS-induced increase in interleukin-6 (IL-6) mRNA expression in the spleen in
dehydrated rats.  IL-6 mRNA expression in the spleen of “Saline + saline,” “Saline + LPS” and “Lisinopril + LPS”
groups.  An ACE inhibitor, lisinopril (20 mg/kg), or saline was administered i.v. 30 min before a single i.v. injection
(at time 0) of LPS (2 µg/kg) in dehydrated rats.  A:  Autoradiograms showing IL-6 mRNA and β-actin mRNA bands
in a representative animal from each group.  B:  Analysis of the density of IL-6 mRNA bands in each group.  Mean
values (± SEM) obtained for IL-6 mRNA in the spleen are expressed in arbitrary units.  The density of the IL-6 mRNA
fraction was normalized with respect to the β-actin density for each sample.  From one-way ANOVA:  for treatment
effect, P < 0.0001 (at 2 h) and P < 0.01 (at 4 h) in panel B.  [   ], number of subjects.
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As shown in Fig. 2A, LPS induced a marked in-
crease in IL-6 mRNA expression at both 2 and 4 h
after the injection (Saline + LPS group versus
Saline + saline group).  Pretreatment with lisinopril
seemed to exert an inhibitory effect on this response
at 2 h (Fig. 2A; Lisinopril + LPS group versus
Saline + LPS group) and a semi-quantitative
analysis of the data (Fig. 2B) revealed that the effect
of lisinopril was indeed statistically significant at 2
h (P < 0.05).
Discussion
The present results showed that the LPS-
induced increase in the expression of splenic
IL-6 mRNA seen in dehydrated rats was
significantly attenuated by treatment with an
ACE inhibitor, as was the fever induced by a
single i.v. injection of LPS.  These results
implicate ANG II in the LPS-induced pro-
duction of IL-6 in dehydrated rats.  Since IL-
6 is thought to be a candidate for a circulating
pyrogenic cytokine (Kluger, 1991), ANG II
may contribute to the febrile response to LPS
by mediating or modulating the LPS-induced
production of IL-6.  This idea is supported by
our previous finding (Watanabe et al., 2000)
that although this ACE inhibitor inhibits
LPS-induced fever, it has no effect on IL-1-
induced fever, indicating the involvement of
ANG II in the LPS-induced production of IL-
1 and ultimately of IL-6.  At this point, it
should be emphasized that IL-1 induces IL-6
in the tissues, and that the IL-6 then enters
the circulation to induce part of the LPS-
induced fever.
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It has recently been reported that ANG II has
proinflammatory properties.  For example, previous
in vitro studies have produced results that led us to
speculate that ANG II contributes to the production
of cytokines from leucocytes stimulated with LPS
(Schindler et al., 1995; Peeters et al., 1998).  Inter-
estingly, application of ANG II onto cultured mes-
angial cells results in the production of IL-6 in vitro
(Moriyama et al., 1995).  Collectively, this evi-
dence supports the present finding that ANG II is
involved the LPS-induced production of the pro-
inflammatory cytokine IL-6 in vivo.  However, it is
unknown exactly how ANG II might contribute to
the LPS-stimulated production of IL-6.  One possi-
bility is that a proinflammatory transcription factor,
nuclear factor kappa-B (NF-κB) might mediate the
effect of ANG II.  In fact, it has been reported that
LPS activates NF-κB in monocytes (Muller et al.,
1993; Baeuerle and Henkel, 1994), that the expres-
sion of IL-6 is controlled at the transcriptional level
through NF-κB (Muller et al., 1993; Baeuerle and
Henkel, 1994) and that ANG II activates NF-κB in
monocytes (Kranzhofer et al., 1999).  Taken togeth-
er, all this suggests the possibility that the activation
of NF-κB by LPS is enhanced by ANG II, leading
to an increase in cytokine production.  This idea
should be tested in detail in future research.
The present study has revealed at the mRNA
level that in vivo, ANG II is involved in the LPS-
induced production of IL-6, which contributes, at
least in part, to the LPS-induced febrile response in
dehydrated rats.  However, it is well known that
ACE not only promotes the production of ANG II,
but also inactivates bradykinin.  Thus, ACE inhibi-
tors increase bradykinin levels and so the elevated
bradykinin could conceivably have affected our re-
sults.  To strengthen our hypothesis on the role of
ANG II in the production of IL-6 in response to
LPS, all the experiments performed in this study
should be repeated, using ANG-receptor antago-
nists, before reaching any final conclusions.  On the
other hand, we have previously shown an attenua-
tion of LPS-induced fever by an ACE inhibitor not
only in dehydrated rats but also in euhydrated rats,
although the effect was greater in the former
(Watanabe et al., 2000).  Thus, the action of ANG II
in promoting cytokine production is not limited to
dehydrated conditions.  It will be interesting to in-
vestigate the significance of the stimulatory action
of ANG II on the production of proinflammatory
cytokines under “euhydrated conditions,” using
relatively high doses of LPS.
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